CATALYST BIOSCIENCES, INC. - FORM 10-K - EX-23.1 - CONSENT OF ERNST & YOUNG LLP - March 11, 2011

Attached files

file filename
10-K - FORM 10-K - CATALYST BIOSCIENCES, INC.d10k.htm
EX-32.1 - CERTIFICATION OF THE CEO PURSUANT TO 18 U.S.C. SECTION 1350 - CATALYST BIOSCIENCES, INC.dex321.htm
EX-32.2 - CERTIFICATION OF THE CFO PURSUANT TO 18 U.S.C. SECTION 1350 - CATALYST BIOSCIENCES, INC.dex322.htm
EX-31.2 - CERTIFICATION OF THE CFO PURSUANT TO RULE 13A-14(A) AND 15D-14A - CATALYST BIOSCIENCES, INC.dex312.htm
EX-31.1 - CERTIFICATION OF THE CEO PURSUANT TO RULE 13A-14(A) AND 15D-14A - CATALYST BIOSCIENCES, INC.dex311.htm
EX-10.4(A) - TARGACEPT, INC. 2006 STOCK INCENTIVE PLAN - CATALYST BIOSCIENCES, INC.dex104a.htm
EX-10.19 - DESCRIPTION OF ANNUAL CASH INCENTIVE PROGRAM - CATALYST BIOSCIENCES, INC.dex1019.htm
EX-10.18 - EXCLUSIVE LICENSE AGREEMENT - CATALYST BIOSCIENCES, INC.dex1018.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the following Registration Statements:

 

  •  

Registration Statement (Form S-8 No. 333-133882) pertaining to the Targacept, Inc. 2000 Equity Incentive Plan,

 

  •  

Registration Statement (Form S-8 No. 333-160331) pertaining to the Targacept, Inc. 2006 Stock Incentive Plan, and

 

  •  

Registration Statement (Form S-3 No. 333-171346) of Targacept, Inc.;

of our reports dated March 11, 2011, with respect to the financial statements of Targacept, Inc. and the effectiveness of internal control over financial reporting of Targacept, Inc., included in this Annual Report (Form 10-K) of Targacept, Inc. for the year ended December 31, 2010.

/s/    Ernst & Young LLP        

Raleigh, North Carolina

March 11, 2011

CATALYST BIOSCIENCES, INC. Reports

Also read